Conference Coverage

Emotional exposure therapy studied for fibromyalgia


 

EXPERT ANALYSIS AT THE 2014 APA CONVENTION

References

CBT, one of the few treatment options for fibromyalgia, has been the "psychological treatment of choice," with techniques that include relaxation training, distraction and pleasant imagery, cognitive reappraisal of distressing thoughts, as well as scheduling and engaging in pleasant activities and healthy behaviors like exercise, he said.

The goal of CBT for fibromyalgia is to shift patients from a "medical treatment cure model" to a "chronic illness self-management" model. However, while CBT has resulted in significant changes over various control conditions, the effect sizes reported in studies have been too small to be noticed by patients, Dr. Lumley said. For example, based on the results of a 2013 Cochrane review, a patient with fibromyalgia could be told that with CBT, the "average patient’s pain improves about 0.5 points more on a 0-10 rating scale," compared with typical treatments, he said (<cf number=\"1\">ystematic reviews.\" </cf>Cochrane Database Syst. Rev. 2013 [doi:10.1002/14651858.CD009796.pub2]).

Fibromyalgia has been considered a psychosomatic condition or an unknown immune disorder in the past, but "a consensus is developing that it is sort of a central nervous system problem, [with] mostly brain, a little bit of spinal cord, and a little bit of the peripheral body involved," he said. In addition to chronic widespread pain and tenderness, symptoms include fatigue and sleep and cognitive problems.

Dr. Lumley had no disclosures; the multicenter study is funded by the National Institutes of Health.

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

Telecare intervention lessens chronic joint pain
MDedge Rheumatology
FDA approves opioid tablet designed to deter abuse if crushed
MDedge Rheumatology
Most kneecap pain can be managed conservatively
MDedge Rheumatology
VIDEO: Dr. Fauci: What you need to know about chikungunya
MDedge Rheumatology
Acetaminophen no better than placebo for acute low back pain
MDedge Rheumatology
House bill would allow corrective action plan for DEA violators
MDedge Rheumatology
Drug compounding law presents challenges, opportunities for physicians
MDedge Rheumatology
Chikungunya vaccine safe, immunogenic in phase I trial
MDedge Rheumatology
DEA moves hydrocodone combination products to schedule II
MDedge Rheumatology
Quality of life gains achieved with comprehensive disease control in RA
MDedge Rheumatology